Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ALXN
Tag: NASDAQ:ALXN
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
December 21, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
November 16, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Entry into a Material...
ME Staff 8-k
-
October 2, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target raised to $175.00 by Barclays
ME Staff
-
September 28, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target set to $156.00 by Credit...
ME Staff
-
September 25, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) price target raised to $195.00 by Citigroup
ME Staff
-
September 25, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) gets downgraded to Hold by Stifel Nicolaus...
ME Staff
-
August 7, 2018
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) had its Outperform rating reiterated by Evercore...
ME Staff
-
July 26, 2018
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Entry into a Material...
ME Staff 8-k
-
June 13, 2018
0
Analyst Activity – Credit Suisse Group Raises Its Price Target On...
ME Staff
-
June 5, 2018
0
1
2
3
...
7
Page 2 of 7
